Therefore, the aim of the present study was to investigate the time- and dose-dependency of DSB induction and repair in blood leucocytes of prostate cancer patients during their first therapy cycle with 177Lu-PSMA. The gene discussed is FOLH1; the disease is prostate carcinoma.